Invention Grant
- Patent Title: Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
-
Application No.: US15206057Application Date: 2016-07-08
-
Publication No.: US09861595B2Publication Date: 2018-01-09
- Inventor: Herriot Tabuteau
- Applicant: Antecip Bioventures II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: K&L Gates LLP
- Agent Brent A. Johnson; Louis C. Cullman
- Main IPC: A01N43/42
- IPC: A01N43/42 ; A61K31/44 ; A61K31/137 ; A61K31/473 ; A61K9/00 ; A61K31/485
Abstract:
This disclosure relates to methods administering various compounds in conjunction with dextromethorphan to a human being. Dosage forms, drug delivery systems, and methods related to dextromethorphan or dextrorphan and bupropion, hydroxybupropion, erythrohydroxybupropion, threohydroxybupropion, or a metabolite or prodrug of any of these compounds are also disclosed
Public/Granted literature
Information query
IPC分类:
